Moreover, the upregulation of thioredoxin (Trx) has been experimentally shown to impede the advancement of insulin resistance in vivo, encompassing both type 1 and type 2 diabetes, as reported by Yamamoto et al.165. This evidence concerns the gene TXN and type 2 diabetes mellitus.